Greater Worcester

Worcester drew a heavy dose of national attention last month when President Obama delivered the commencement address...

Karyopharm Therapeutics, a life sciences startup, was a rising star in Natick until the company announced last month it was moving to a bigger headquarters in Newton at the end of July. One reason? There wasn't enough laboratory space to expand.

Lenders are finding themselves walking a tightrope between providing lower-income Americans with quality housing and keeping their...

DOES WORCESTER FLUNK WITH SMALL BUSINESSES? According to a survey by Thumbtack.com and the Ewing Marion Kauffman...

Home to 11 percent of American drug development and more than a fifth of all U.S. biotech venture capital, Massachusetts has particularly piqued the interests of Israelis with life sciences backgrounds.

Five years after the Great Recession officially ended, small employers in Massachusetts are suddenly feeling better about...

A Leominster attorney has purchased downtown Worcester's Guaranty Building for $9.93 million.

In what has been termed the biggest corporate takeover of 2014 to date, Illinois-drug maker AbbVie, which employs about 700 in Worcester at a research and development facility, has agreed to buy Dublin-based Shire in a $54 billion deal announced Friday morning.

Capital Group Properties of Southborough has agreed to purchase 8.5-acres of land for an undisclosed amount in Shrewsbury for an affordable housing development, the company said.

A $420,000 grant from the National Institutes of Health (NIH) will allow a team of Worcester Polytechnic Institute researchers to test a plant-based therapy WPI is developing for the treatment of malaria.